CY1106111T1 - Ανασυνδυασμενος σταθepος κυτταρικος κλωνος, η παρασκευη και χρησιμοποιηση του - Google Patents

Ανασυνδυασμενος σταθepος κυτταρικος κλωνος, η παρασκευη και χρησιμοποιηση του

Info

Publication number
CY1106111T1
CY1106111T1 CY20061100911T CY061100911T CY1106111T1 CY 1106111 T1 CY1106111 T1 CY 1106111T1 CY 20061100911 T CY20061100911 T CY 20061100911T CY 061100911 T CY061100911 T CY 061100911T CY 1106111 T1 CY1106111 T1 CY 1106111T1
Authority
CY
Cyprus
Prior art keywords
cell clone
protein
preparation
stable
recombinant
Prior art date
Application number
CY20061100911T
Other languages
English (en)
Inventor
Manfred Reiter
Wolfgang Mundt
Friedrich Dorner
Original Assignee
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3683861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106111(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Aktiengesellschaft filed Critical Baxter Aktiengesellschaft
Publication of CY1106111T1 publication Critical patent/CY1106111T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Περιγράφονται ένας σταθερός ανασυνδυασμένος κυτταρικός κλώνος, ο οποίος είναι σταθερός για τουλάχιστον 40 γενιές σε ελεύθερο ορού και πρωτεϊνών μέσο, μία βιομάζα που προήλθε από τον πολλαπλασιασμό του σταθερού κυτταρικού κλώνου σε συνθήκες καλλιέργειας ελεύθερες ορού και πρωτεϊνών και μία μέθοδος παρασκευής ανασυνδυασμένων πρωτεϊνών μέσω της βιομάζας. Επιπλέον, η εφεύρεση αφορά μία μέθοδο παραγωγής σταθερών ανασυνδυασμένων κυτταρικών κλώνων. Η εφεύρεση αφορά περαιτέρω την παρασκευή μιας ανασυνδυασμένης πρωτεΐνης σε ένα συνθετικό ελάχιστο μέσο ελεύθερο ορού και πρωτεϊνών.
CY20061100911T 1999-08-05 2006-07-03 Ανασυνδυασμενος σταθepος κυτταρικος κλωνος, η παρασκευη και χρησιμοποιηση του CY1106111T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AT1999/000197 WO2001011021A1 (de) 1999-08-05 1999-08-05 Rekombinanter stabiler zellklon, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
CY1106111T1 true CY1106111T1 (el) 2011-06-08

Family

ID=3683861

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100911T CY1106111T1 (el) 1999-08-05 2006-07-03 Ανασυνδυασμενος σταθepος κυτταρικος κλωνος, η παρασκευη και χρησιμοποιηση του

Country Status (11)

Country Link
EP (1) EP1200561B1 (el)
JP (1) JP2003506077A (el)
AT (1) ATE330003T1 (el)
AU (1) AU780810B2 (el)
CA (1) CA2381173A1 (el)
CY (1) CY1106111T1 (el)
DE (1) DE59913565D1 (el)
DK (1) DK1200561T3 (el)
ES (1) ES2267280T3 (el)
PT (1) PT1200561E (el)
WO (1) WO2001011021A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
HUP0301245A3 (en) * 2000-10-02 2005-12-28 Novo Nordisk Healthcare Ag Tmethod for the production of vitamin k-dependent proteins
KR20040039472A (ko) 2001-10-02 2004-05-10 노보 노르디스크 헬스 케어 악티엔게젤샤프트 진핵 세포에서 재조합체 단백질의 제조 방법
HUP0402226A2 (hu) * 2001-11-28 2005-02-28 Sandoz Ag. Eljárás sejttenyésztésre
US20050123532A1 (en) * 2001-12-04 2005-06-09 Takaharu Kouno Method of activating protein
EP1520008B1 (en) 2002-07-09 2012-09-05 Baxter International Inc. Animal protein free media for cultivation of cells
DE10338531A1 (de) * 2003-08-19 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Reklonierung von Produktionszellen
US8669109B2 (en) 2003-08-19 2014-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methods of producing proteins in Chinese hamster ovary (CHO) cells
BRPI0417916A (pt) * 2003-12-31 2007-04-10 Merck Patent Gmbh proteìna de fusão de fc-eritropoietina com farmacocinética melhorada
AU2011221414B2 (en) * 2004-10-29 2012-09-20 Takeda Pharmaceutical Company Limited Animal Protein-Free Media for Cultivation of Cells
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
ATE541919T1 (de) 2005-02-11 2012-02-15 Novo Nordisk Healthcare Ag Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält
ES2474573T3 (es) 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
EP2977461A1 (en) * 2008-11-12 2016-01-27 Baxalta Incorporated Method of producing serum-free insulin-free factor vii
WO2024024671A1 (ja) * 2022-07-27 2024-02-01 不二製油グループ本社株式会社 動物細胞増殖促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4313620A1 (de) * 1993-04-26 1994-10-27 Biotechnolog Forschung Gmbh Hamsterzellinien und Verfahren zur Glykoproteingewinnung
EP0666312A1 (en) * 1994-02-08 1995-08-09 Wolfgang A. Renner Process for the improvement of mammalian cell growth
EP1213030B1 (en) * 1994-11-10 2009-04-22 Baxter Healthcare SA Method for producing biologicals in protein-free culture
AU4302796A (en) * 1994-12-16 1996-07-03 Novartis Ag Production of recombinant secretory component
AUPN442295A0 (en) * 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein

Also Published As

Publication number Publication date
PT1200561E (pt) 2006-09-29
EP1200561A1 (de) 2002-05-02
AU5363699A (en) 2001-03-05
DE59913565D1 (de) 2006-07-27
ES2267280T3 (es) 2007-03-01
ATE330003T1 (de) 2006-07-15
JP2003506077A (ja) 2003-02-18
CA2381173A1 (en) 2001-02-15
WO2001011021A1 (de) 2001-02-15
AU780810B2 (en) 2005-04-21
EP1200561B1 (de) 2006-06-14
DK1200561T3 (da) 2006-10-16

Similar Documents

Publication Publication Date Title
CY1106111T1 (el) Ανασυνδυασμενος σταθepος κυτταρικος κλωνος, η παρασκευη και χρησιμοποιηση του
CY1107447T1 (el) Ετερολογη εκφραση πρωτεϊνων των neisseria
TR200002284T2 (tr) Mage ailesinden tümör ile ilgili tümör türevleri
EA200000109A1 (ru) Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения
IL219969A (en) Cell culture containing recombinant cho cells expressing protein factor viii
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
DK1220934T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner med anvendelse af apoptoseinhibitorer
ATE500323T1 (de) Subtilisin-variante
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
DK1200583T3 (da) Fremstilling af beta-foldeblad-proteiner med specifikke bindingsegenskaber
ATE125157T1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
ATE267255T1 (de) Ob proteinderivate mit verlängerter halbwertzeit
ATE197068T1 (de) Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
DE69939903D1 (de) Methoden zur herstellung von helpervirusfreien präparationen von freien rekombinenten aav-vektoren mit hohem titer
DK0480949T4 (da) Fremstilling af virusvaccine
NZ334146A (en) Generating immortalised chicken cells to be used for propagating virus and producing recombinant proteins
DE60042273D1 (de) Antitumorantikörper, proteine und deren verwendung
BR0113623A (pt) Proteìnas sintéticas de estìmulo da eritropoiese
BR9911388A (pt) Imunógeno de somatostatina sintético para promoção de crescimento em animais de fazenda
LT2005053A (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
DE59914878D1 (de) Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika
NO20005321L (no) Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette
LO STUDIES IN SIMIAN VIRUS 40 INDUCED TRANSFORMATION.
EP0145589A3 (fr) Culture de cellules eucaryotes productrices d'une protéine vaccinante, notamment d'antigène HBs